Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

PHASE4CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Hepatitis B Vaccine
Interventions
BIOLOGICAL

Engerix™-B Kinder

Intramuscular injection, 1 dose

Trial Locations (35)

10967

GSK Investigational Site, Berlin

12679

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

13507

GSK Investigational Site, Berlin

24161

GSK Investigational Site, Kiel

24937

GSK Investigational Site, Flensburg

24943

GSK Investigational Site, Flensburg

24944

GSK Investigational Site, Flensburg

25813

GSK Investigational Site, Husum

25821

GSK Investigational Site, Bredstedt

32427

GSK Investigational Site, Minden

32457

GSK Investigational Site, Porta Westfalica

32584

GSK Investigational Site, Löhne

48163

GSK Investigational Site, Münster

54294

GSK Investigational Site, Trier

55131

GSK Investigational Site, Mainz

67227

GSK Investigational Site, Frankenthal

67547

GSK Investigational Site, Worms

69120

GSK Investigational Site, Heidelberg

70469

GSK Investigational Site, Stuttgart

71720

GSK Investigational Site, Oberstenfeld

75172

GSK Investigational Site, Pforzheim

75217

GSK Investigational Site, Birkenfeld

76189

GSK Investigational Site, Karlsruhe

77654

GSK Investigational Site, Offenburg

77704

GSK Investigational Site, Oberkirch

77955

GSK Investigational Site, Ettenheim

78532

GSK Investigational Site, Tuttlingen

81241

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

83684

GSK Investigational Site, Tegernsee

86916

GSK Investigational Site, Kaufering

95463

GSK Investigational Site, Bindlach

97816

GSK Investigational Site, Lohr

04103

GSK Investigational Site, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY